Stringer William, Bryant Roy
Module 3 Pharma Services, St. Petersburg, Florida, USA.
Clin Ophthalmol. 2010 Oct 5;4:1119-24. doi: 10.2147/OPTH.S12441.
To compare the dose uniformity of difluprednate ophthalmic emulsion 0.05% (Durezol(®)) with both branded and generic prednisolone acetate ophthalmic suspension 1% under different simulated patient usage conditions.
Drug concentrations of difluprednate emulsion, branded prednisolone acetate suspension (Pred Forte(®)) and generic prednisolone acetate suspension following three storage conditions (upright, then shaken; upright, not shaken; inverted, not shaken) were analyzed by high performance liquid chromatography assay and results were reported as percent of declared concentration. Two drops were dispensed every four hours four times daily.
Regardless of bottle orientation and shaking, all difluprednate emulsion concentrations at each time point analyzed were within 15% of declared concentration. Both branded and generic prednisolone acetate suspension concentrations varied substantially throughout the study. For the bottle stored upright and not shaken, 46% of the branded concentrations were not within 15% of declared concentration; for the bottle stored upright and shaken prior to use, 60% failed to meet this criterion. None of the branded concentrations from the inverted and not shaken bottle was within 15% of declared concentration. Generic prednisolone concentrations demonstrated the poorest dose uniformity, with 96% of the concentrations from the inverted and not shaken bottle not within 15% of declared concentration; 94% of the concentrations from the upright and shaken bottle and 87% from the upright and not shaken bottle similarly failed to meet this criterion.
Dose uniformity of Durezol emulsion was predictable in all simulated patient usage conditions, whereas the drop concentrations of Pred Forte and generic prednisolone acetate suspensions were highly variable throughout the study. Drop concentrations are more predictable with Durezol emulsion than with either prednisolone acetate suspension.
比较0.05%地氟泼尼酯眼用乳剂(Durezol®)与1%品牌及非专利醋酸泼尼松龙眼用混悬液在不同模拟患者使用条件下的剂量均匀性。
采用高效液相色谱分析法分析地氟泼尼酯乳剂、品牌醋酸泼尼松龙混悬液(Pred Forte®)和非专利醋酸泼尼松龙混悬液在三种储存条件(直立,然后摇晃;直立,不摇晃;倒置,不摇晃)下的药物浓度,并将结果报告为标示浓度的百分比。每天四次,每四小时滴注两滴。
无论瓶子的放置方向和是否摇晃,在每个分析时间点,所有地氟泼尼酯乳剂浓度均在标示浓度的15%以内。在整个研究过程中,品牌及非专利醋酸泼尼松龙混悬液的浓度均有很大变化。对于直立放置且未摇晃的瓶子,46%的品牌浓度不在标示浓度的15%以内;对于直立放置并在使用前摇晃的瓶子,60%不符合该标准。倒置且未摇晃的瓶子中,没有一个品牌浓度在标示浓度的15%以内。非专利醋酸泼尼松龙浓度的剂量均匀性最差,倒置且未摇晃的瓶子中96%的浓度不在标示浓度的15%以内;直立且摇晃的瓶子中94%的浓度以及直立且未摇晃的瓶子中87%的浓度同样不符合该标准。
在所有模拟患者使用条件下,Durezol乳剂的剂量均匀性是可预测的,而Pred Forte和非专利醋酸泼尼松龙混悬液的滴剂浓度在整个研究过程中变化很大。与醋酸泼尼松龙混悬液相比,Durezol乳剂的滴剂浓度更具可预测性。